News
Are Medical Stocks Lagging Ardelyx (ARDX) This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Ardelyx (ARDX) one of those stocks right now? A quick glance at the company's
Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Are Investors Undervaluing Custom Truck One Source (CTOS) Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop
Has GoPro (GPRO) Outpaced Other Consumer Discretionary Stocks This Year?
The Consumer Discretionary group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is GoPro (GPRO) one of those stocks right now
Are Investors Undervaluing Mercedes-Benz Group AG (MBGYY) Right Now?
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always
Is The New York Times Company (NYT) Stock Outpacing Its Consumer Staples Peers This Year?
The Consumer Staples group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is New York Times Co. (NYT) one of those stocks right
Here's Why UMB Financial (UMBF) is a Strong Value Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research
Is Dutch Bros Winning the Coffee Wars With Traffic, Not Pricing?
Dutch Bros Inc. BROS is increasingly standing out in the crowded coffee landscape by leaning on traffic growth rather than aggressive pricing. The company’s third-quarter 2025 results underscore a
Buy 5 Stocks With High ROE as U.S. Economy Appears on Firm Footing
The broader equity markets continued to trade in record territory after a minor blip mid-week. The uptrend was buoyed by relatively modest job market conditions, with the December jobs report
With ROIC at 19-Year Highs, Is CCL Entering a New Profitability Cycle?
Carnival Corporation & plc’s CCL latest earnings call highlights a potential inflection point in its long-term profitability. Management reported return on invested capital (“ROIC”) above 13% in
Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround
A downtrend has been apparent in Aquestive Therapeutics (AQST) lately with too much selling pressure. The stock has declined 37% over the past four weeks. However, given the fact that it is now in
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO)
AngioDynamics (ANGO) has been on a downward spiral lately with significant selling pressure. After declining 25% over the past four weeks, the stock looks well positioned for a trend reversal as it
SMCI Plunges 45% in 3 Months: Time to Buy, Sell or Hold the Stock?
Super Micro Computer SMCI shares have plunged 44.9% in the past three months, underperforming the Zacks Computer- Storage Devices industry and the Zacks Computer and Technology sector’s appreciation
Can Estee Lauder's Fragrance Strength Drive Top-Line Growth?
The Estee Lauder Companies Inc. (EL) has pointed to fragrance as a meaningful driver of organic sales growth. In the first quarter of fiscal 2026, fragrance was the company’s strongest-performing
Exelixis Posts Preliminary '25 Results, Issues '26 Outlook
Exelixis, Inc. EXEL reported preliminary, unaudited financial results for fiscal year 2025, issued financial guidance for fiscal 2026, and provided a business update.
However, the stock is down in
INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced
Shares of Insmed INSM gained more than 3% on Friday after the company reported preliminary sales numbers for full-year 2025. It also outlined some expected milestones related to its commercial
Wall Street Analysts See Coupang (CPNG) as a Buy: Should You Invest?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Wall Street Bulls Look Optimistic About Merck (MRK): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Is P&G (PG) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Should You Invest in Gray Media (GTN) Based on Bullish Wall Street Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Wall Street Analysts Think CleanSpark (CLSK) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
CRISPR Therapeutics (CRSP) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Wall Street Analysts See Toyota Motor (TM) as a Buy: Should You Invest?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Why This 1 Medical Stock Could Be a Great Addition to Your Portfolio
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
The Zacks Premium
Wall Street Bulls Look Optimistic About Clear Secure (YOU): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm


